期刊文献+

足细胞病变与慢性肾脏病进展 被引量:2

下载PDF
导出
摘要 慢性肾脏病(CKD)是2001年由美国肾脏病基金会(NKF)首次提出。CKD由多种不同病因引起,可发生在任何年龄段人群,具有较高的致残率及致死率,很大比例的CKD患者最终进展至终末期肾衰竭而接受肾脏替代治疗。CKD进展的损伤机制十分复杂,其特征主要是由于各种初始原因触发了肾脏纤维化的过程,最终导致尿毒症的发生。
出处 《临床肾脏病杂志》 2011年第10期478-480,共3页 Journal Of Clinical Nephrology
基金 国家自然科学基金资助课题(30871167)
  • 相关文献

参考文献1

二级参考文献1

共引文献2

同被引文献25

  • 1Takayanagi R,Inoguchi T,Ohnaka K.Clinical and experimental evidence for oxidative stress as an exacerbating factor of diabetes mellitus.J Clin Biochem Nutr,2011,48:72-77.
  • 2Maezawa Y,Takemoto M,Yokote K.Cell biology of diabetic nephropathy:Roles of endothelial cells,tubulointerstitial cells and podocytes.J Diabetes Investig,2015,6:3-15.
  • 3Tossidou I,Teng B,Drobot L,et al.CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.J Biol Chem,2010,285:25285-25295.
  • 4Vitureira N,Andrés R,Pérez-Martínez E,et al.Podocalyxin is a novel polysialylated neural adhesion protein with multiple roles in neural development and synapse formation.PLoS One,2010,5:e12003.
  • 5Viollet B,Guigas B,Sanz Garcia N,et al.Cellular and molecular mechanisms of metformin:an overview.Clin Sci(Lond),2012,122:253-270.
  • 6Alhaider AA,Korashy HM,Sayed-Ahmed MM,et al.Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression.Chem Biol Interact,2011,192:233-242.
  • 7Drossopoulou GI,Tsotakos NE,Tsilibary EC.Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucosetreated human podocytes.Am J Physiol Renal Physiol,2009,297:F594-F603.
  • 8Merscher S,Pedigo CE,Mendez AJ.Metabolism,energetics,and lipid biology in the podocyte-cellular cholesterol-mediated glomerular injury.Front Endocrinol(Lausanne),2014,5:169.
  • 9Lettieri Barbato D,Vegliante R,Desideri E,et al.Managing lipid metabolism in proliferating cells:new perspective for metformin usage in cancer therapy.Biochim Biophys Acta,2014,1845:317-324.
  • 10Pernicova I,Korbonits M.Metformin--mode of action and clinical implications for diabetes and cancer.Nat Rev Endocrinol,2014,10:143-156.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部